GlassScriptPhysician profile
Jason Griffin
NPI 1720306277
$17,472.53
in general payments reported to CMS, 2019-2025
21 companies · $1,453 in 2025
The $1,453 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,412 · 2020: $335 · 2021: $7,499 · 2022: $4,309 · 2023: $954 · 2024: $510 · 2025: $1,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,585 · Travel and Lodging: $1,183 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,585.02 |
| Travel and Lodging | $1,182.70 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $10,231.59 | 2019-2024 | |
| Arthrex, INC. | $4,588.38 | 2019-2025 | |
| Smith+Nephew, INC. | $866.52 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System |
| Stryker Corporation | $355.15 | 2019-2025 | Alphavent, Air, Gamma |
| Aesculap Biologics, LLC | $225.23 | 2021-2023 | Novocart 3d |
| Bioventus LLC | $219.86 | 2022-2025 | Xcell, Durolane, Exogen Ultrasound Bone Healing System |
| Miach Orthopaedics, INC. | $193.54 | 2025 | |
| Pacira Therapeutics, INC. | $143.53 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $125.95 | 2019-2025 | Euflexxa |
| Bodycad USA Corp | $112.29 | 2024 | Fine Osteotomy |
| Vericel Corporation | $84.56 | 2021-2025 | Maci |
| Horizon Therapeutics Plc | $71.72 | 2022 | |
| Skeletal Dynamics INC | $67.52 | 2019 | |
| Depuy Synthes Sales INC. | $61.19 | 2019-2025 | Monovisc |
| Pfizer INC. | $26.36 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $22.51 | 2019 | |
| Dynasplint Systems INC. | $18.15 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.34 | 2023 | Seglentis |
| Pacira Pharmaceuticals Incorporated | $15.04 | 2022 | |
| Novo Nordisk INC | $14.99 | 2023 | Rybelsus, Ozempic |
| Zyla Life Sciences, INC. | $12.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.